RAB11-mediated trafficking in host-pathogen interactions

Nature Reviews Microbiology

Volumn 12, Issue 9, 2014, Pages 624-634

  Guichard, Annabel ^a   Nizet, Victor ^b,c   Bier, Ethan ^a  

^a SECTION OF CELL AND DEVELOPMENTAL BIOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; CHOLERA TOXIN; EXOCYST; RAB11 PROTEIN;

BACILLUS ANTHRACIS; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; HOST PATHOGEN INTERACTION; HUMAN; INNATE IMMUNITY; INTESTINAL BARRIER INTEGRITY; INTESTINE FUNCTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; VIBRIO CHOLERAE; VIRUS; VIRUS INFECTION;

ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CHOLERA TOXIN; EXOCYTOSIS; HANTAVIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INFECTION; INTERCELLULAR JUNCTIONS; PHAGOSOMES; PROTEIN TRANSPORT; RAB GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; VIBRIO CHOLERAE;

EID: 84906270294     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro3325     Document Type: Review

References (82)

1. Stenmark, H. Rab GTPases as coordinators of vesicle traffic. Nature Rev. Mol. Cell Biol. 10, 513-525 (2009).
2. Heider, M. R. & Munson, M. Exorcising the exocyst complex. Traffic 13, 898-907 (2012).
3. Kelly, E. E., Horgan, C. P. & McCaffrey, M. W. Rab11 proteins in health and disease. Biochem. Soc. Trans. 40, 1360-1367 (2012).
4. Lim, Y. S., Chua, C. E. & Tang, B. L. Rabs and other small GTPases in ciliary transport. Biol. Cell 103, 209-221 (2011).
5. Knodler, A. et al. Coordination of Rab8 and Rab11 in primary ciliogenesis. Proc. Natl Acad. Sci. USA 107, 6346-6351 (2010).
6. Apodaca, G. Opening ahead: Early steps in lumen formation revealed. Nature Cell Biol. 12, 1026-1028 (2010).
7. Novick, P. et al. Interactions between Rabs, tethers, SNAREs and their regulators in exocytosis. Biochem. Soc. Trans. 34, 683-686 (2006).
8. Husebye, H. et al. The Rab11a GTPase controls Toll-like receptor 4 induced activation of interferon regulatory factor 3 on phagosomes. Immunity 33, 583-596 (2010).
9. Los, F. C. et al. RAB 5-And RAB 11 dependent vesicle-Trafficking pathways are required for plasma membrane repair after attack by bacterial pore-forming toxin. Cell Host Microbe 9, 147-157 (2011).
10. Ishikawa, H., Ma, Z. & Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788-792 (2009).
11. Simicek, M. et al. The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune response. Nature Cell Biol. 15, 1220-1230 (2013).
12. Prigent, M. et al. ARF6 controls post-endocytic recycling through its downstream exocyst complex effector. J. Cell Biol. 163, 1111-1121 (2003).
13. Fielding, A. B. et al. Rab11 FIP3 and FIP4 interact with Arf6 and the exocyst to control membrane traffic in cytokinesis. EMBO J. 24, 3389-3399 (2005).
14. Guichard, A. et al. Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11/Sec15 exocyst. Nature 467, 854-858 (2010).
15. Guichard, A. et al. Cholera toxin disrupts barrier function by inhibiting exocyst-mediated trafficking of host proteins to intestinal cell junctions. Cell Host Microbe 14, 294-305 (2013).
16. Nichols, C. D. & Casanova, J. E. Salmonella-directed recruitment of new membrane to invasion foci via the host exocyst complex. Curr. Biol. 20, 1316-1320 (2010).
17. Brock, S. C., Goldenring, J. R. & Crowe, J. E. Jr. Apical recycling systems regulate directional budding of respiratory syncytial virus from polarized epithelial cells. Proc. Natl Acad. Sci. USA 100, 15143-15148 (2003).
18. Rowe, R. K., Suszko, J. W. & Pekosz, A. Roles for the recycling endosome, Rab8, and Rab11 in hantavirus release from epithelial cells. Virology 382, 239-249 (2008).
19. Mounier, J. et al. Shigella effector IpaB-induced cholesterol relocation disrupts the Golgi complex and recycling network to inhibit host cell secretion. Cell Host Microbe 12, 381-389 (2012).
20. Rejman Lipinski, A. et al. Rab6 and Rab11 regulate Chlamydia trachomatis development and golgin-84 dependent Golgi fragmentation. PLoS Pathog. 5, e1000615 (2009).
21. Koch, R. (ed.) Beitrage zur Biologie der Pflanzen Vol. 2 (J. U. Kern's Verlag (Max Müller)) (in German) (1876).
22. Koch, R. Sechster Bericht der deutschen Wissenschaftlichen Commission zur Enforschung der Cholera, Geh Regierungsraths Dr Koch. Dtsch. Med. Wochenschr. 10, 191-192 (in German) (1884).
23. Chamberland, C. (ed). Le charbon et la vaccination charbonneuse d'apres les travaux recents de M. Pasteur (ed. Tignol, B.) (Bernard Tignol) (in French) (1883).
24. Pasteur, L., Chamberland, C. & Roux, E. Compte rendu sommaire des experiences faites a Pouilly-le Fort, pres Melun, sur la vaccination charbonneuse. Cr. Acad. Sci. Paris 92, 1393-1398 (in French) (1881).
25. Guichard, A., Nizet, V. & Bier, E. New insights into the biological effects of anthrax toxins: Linking cellular to organismal responses. Microbes Infect. 14, 97-118 (2012).
26. Mourez, M. Anthrax toxins. Rev. Physiol. Biochem. Pharmacol. 152, 135-164 (2004).
27. Liu, S. et al. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice. Cell Host Microbe 8, 455-462 (2010).
28. Pezard, C., Berche, P. & Mock, M. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 59, 3472-3477 (1991).
29. Liu, S. et al. Key tissue targets responsible for anthrax-Toxin-induced lethality. Nature 501, 63-68 (2013).
30. Brand, A. H. & Perrimon, N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415 (1993).
31. Guichard, A., Park, J. M., Cruz-Moreno, B., Karin, M. & Bier, E. Anthrax lethal factor and edema factor act on conserved targets in Drosophila. Proc. Natl Acad. Sci. USA 103, 3244-3249 (2006).
32. Jafar-Nejad, H. et al. Sec15, a component of the exocyst, promotes Notch signaling during the asymmetric division of Drosophila sensory organ precursors. Dev. Cell 9, 351-363 (2005).
33. De Haan, L. & Hirst, T. R. Cholera toxin: A paradigm for multi-functional engagement of cellular mechanisms. Mol. Membr. Biol. 21, 77-92 (2004).
34. Sack, D. A., Sack, R. B., Nair, G. B. & Siddique, A. K. Cholera. Lancet 363, 223-233 (2004).
35. Barrett, K. E. & Keely, S. J. Chloride secretion by the intestinal epithelium: Molecular basis and regulatory aspects. Annu. Rev. Physiol. 62, 535-572 (2000).
36. Gabriel, S. E., Brigman, K. N., Koller, B. H., Boucher, R. C. & Stutts, M. J. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266, 107-109 (1994).
37. Mathan, M. M., Chandy, G. & Mathan, V. I. Ultrastructural changes in the upper small intestinal mucosa in patients with cholera. Gastroenterology 109, 422-430 (1995).
38. Ahuja, N., Kumar, P. & Bhatnagar, R. The adenylate cyclase toxins. Crit. Rev. Microbiol. 30, 187-196 (2004).
39. Sears, C. L. & Kaper, J. B. Enteric bacterial toxins: Mechanisms of action and linkage to intestinal secretion. Microbiol. Rev. 60, 167-215 (1996).
40. Weiglmeier, P R., Rosch, P. & Berkner, H. Cure and curse: E. coli heat-stable enterotoxin and its receptor guanylyl cyclase C. Toxins 2, 2213-2229 (2010).
41. Brumell, J. H. & Scidmore, M. A. Manipulation of Rab GTPase function by intracellular bacterial pathogens. Microbiol. Mol. Biol. Rev. 71, 636-652 (2007).
42. Ray, K., Marteyn, B., Sansonetti, P. J. & Tang, C. M. Life on the inside: The intracellular lifestyle of cytosolic bacteria. Nature Rev. Microbiol. 7, 333-340 (2009).
43. Hayward, R. D. & Koronakis, V. Direct nucleation and bundling of actin by the SipC protein of invasive Salmonella. EMBO J. 18, 4926-4934 (1999).
44. Rzomp, K. A., Scholtes, L. D., Briggs, B. J., Whittaker, G. R. & Scidmore, M. A. Rab GTPases are recruited to chlamydial inclusions in both a species-dependent and species-independent manner. Infect. Immun. 71, 5855-5870 (2003).
45. Varthakavi, V. et al. The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV 1 particle release. Traffic 7, 298-307 (2006).
46. Sfakianos, J. N. & Hunter, E. M PMV capsid transport is mediated by Env/Gag interactions at the pericentriolar recycling endosome. Traffic 4, 671-680 (2003).
47. Sayner, S. L. et al. Paradoxical cAMP-induced lung endothelial hyperpermeability revealed by Pseudomonas aeruginosa ExoY. Circ. Res. 95, 196-203 (2004).
48. Sack, R. B. The discovery of cholera-like enterotoxins produced by Escherichia coli causing secretory diarrhoea in humans. Indian J. Med. Res. 133, 171-180 (2011).
49. Carbonetti, N. H. Pertussis toxin and adenylate cyclase toxin: Key virulence factors of Bordetella pertussis and cell biology tools. Future Microbiol. 5, 455-469 (2010).
50. Bai, G., Knapp, G. S. & McDonough, K. A. Cyclic AMP signalling in mycobacteria: Redirecting the conversation with a common currency. Cell. Microbiol. 13, 349-358 (2011).
51. Wang, M. et al. Microbial hijacking of complement-Toll-like receptor crosstalk. Sci. Signal 3, ra11 (2010).
52. Michankin, B. N., Chevchenko, L. A. & Asseeva, L. E. Adenylate cyclase. A possible factor in the pathogenicity of Yersinia pestis. Bull. Soc. Pathol. Exot. 85, 17-21 (1992).
53. Bliska, J. B. Yersinia inhibits host signaling by acetylating MAPK kinases. ACS Chem. Biol. 1, 349-351 (2006).
54. Huffman, D. L. et al. Mitogen-Activated protein kinase pathways defend against bacterial pore-forming toxins. Proc. Natl Acad. Sci. USA 101, 10995-11000 (2004).
55. Park, J. M., Ng, V. H., Maeda, S., Rest, R. F. & Karin, M. Anthrolysin O and other Gram-positive cytolysins are Toll-like receptor 4 agonists. J. Exp. Med. 200, 1647-1655 (2004).
56. Moayeri, M. & Leppla, S. H. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol. Aspects Med. 30, 439-455 (2009).
57. Tournier, J. N., Rossi Paccani, S., Quesnel-Hellmann, A. & Baldari, C. T. Anthrax toxins: A weapon to systematically dismantle the host immune defenses. Mol. Aspects Med. 30, 456-466 (2009).
58. Queen, J. & Satchell, K. J. Promotion of colonization and virulence by cholera toxin is dependent on neutrophils. Infect. Immun. 81, 3338-3345 (2013).
59. Grinberg, L. M., Abramova, F. A., Yampolskaya, O. V., Walker, D. H. & Smith, J. H. Quantitative pathology of inhalational anthrax I: Quantitative microscopic findings. Mod. Pathol. 14, 482-495 (2001).
60. Ishikawa, H. & Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674-678 (2008).
61. Chien, Y. et al. RalB GTPase-mediated activation of the IκB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 127, 157-170 (2006).
62. Cherry, S. Genomic RNAi screening in Drosophila S2 cells: What have we learned about host-pathogen interactions? Curr. Opin. Microbiol. 11, 262-270 (2008).
63. Guttman, J. A. & Finlay, B. B. Tight junctions as targets of infectious agents. Biochim. Biophys. Acta 1788, 832-841 (2009).
64. Wilke, G. A. & Bubeck Wardenburg, J. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α-hemolysin-mediated cellular injury. Proc. Natl Acad. Sci. USA 107, 13473-13478 (2010).
65. Berube, B. J. & Bubeck Wardenburg, J. Staphylococcus aureus α-Toxin: Nearly a century of intrigue. Toxins 5, 1140-1166 (2013).
66. Powers, M. E., Kim, H. K., Wang, Y. & Bubeck Wardenburg, J. ADAM10 mediates vascular injury induced by Staphylococcus aureus α-hemolysin. J. Infect. Dis. 206, 352-356 (2012).
67. Inoshima, N., Wang, Y. & Bubeck Wardenburg, J. Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infection. J. Invest. Dermatol. 132, 1513-1516 (2012).
68. Inoshima, I. et al. A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nature Med. 17, 1310-1314 (2011).
69. Weber, S. et al. The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling. Development 138, 495-505 (2011).
70. Gibb, D. R. et al. ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo. J. Exp. Med. 207, 623-635 (2010).
71. Tian, L. et al. ADAM10 is essential for proteolytic activation of Notch during thymocyte development. Int. Immunol. 20, 1181-1187 (2008).
72. Hartmann, D. et al. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for α-secretase activity in fibroblasts. Hum. Mol. Genet. 11, 2615-2624 (2002).
73. Wen, C., Metzstein, M. M. & Greenwald, I. SUP 17, a Caenorhabditis elegans ADAM protein related to Drosophila KUZBANIAN, and its role in LIN 12/NOTCH signalling. Development 124, 4759-4767 (1997).
74. Pan, D. & Rubin, G. M. Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell 90, 271-280 (1997).
75. Debellis, L. et al. The Vibrio cholerae cytolysin promotes chloride secretion from intact human intestinal mucosa. PLoS ONE 4, e5074 (2009).
76. Valeva, A. et al. A cellular metalloproteinase activates Vibrio cholerae pro-cytolysin. J. Biol. Chem. 279, 25143-25148 (2004).
77. Husmann, M. et al. Elimination of a bacterial pore-forming toxin by sequential endocytosis and exocytosis. FEBS Lett. 583, 337-344 (2009).
78. Husmann, M. et al. Differential role of p38 mitogen activated protein kinase for cellular recovery from attack by pore-forming S. aureus α-Toxin or streptolysin O. Biochem. Biophys. Res. Commun. 344, 1128-1134 (2006).
79. Lizak, M. & Yarovinsky, T. O. Phospholipid scramblase 1 mediates type I interferon-induced protection against staphylococcal α-Toxin. Cell Host Microbe 11, 70-80 (2012).
80. Ali, S. R. et al. Anthrax toxin induces macrophage death by p38 MAPK inhibition but leads to inflammasome activation via ATP leakage. Immunity 35, 34-44 (2011).
81. Smith, H. & Keppie, J. Observations on experimental anthrax; demonstration of a specific lethal factor produced in vivo by Bacillus anthracis. Nature 173, 869-870 (1954).
82. Chitlaru, T., Altboum, Z., Reuveny, S. & Shafferman, A. Progress and novel strategies in vaccine development and treatment of anthrax. Immunol. Rev. 239, 221-236 (2011)..